4.7 Article

Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study

Journal

LANCET INFECTIOUS DISEASES
Volume 23, Issue 1, Pages 56-66

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S1473-3099(22)00525-4

Keywords

-

Ask authors/readers for more resources

This study describes the epidemiological changes of respiratory syncytial virus (RSV) among children under 5 years old in England since 2020. The study found that RSV activity was significantly reduced during the winter of 2020-21, but an unprecedented summer surge occurred in 2021. Rating: 9/10.
Background Seasonal epidemics of respiratory syncytial virus (RSV) cause a clinically significant burden of disease among young children. Non-pharmaceutical interventions targeted at SARS-CoV-2 have affected the activity of other respiratory pathogens. We describe changes in the epidemiology of RSV among children younger than 5 years in England since 2020.Methods Surveillance data on RSV infections, comprising laboratory-confirmed cases, proportion of positive tests, hospital admissions for RSV-attributable illness, and syndromic indicators for RSV-associated disease (emergency department attendances for acute bronchitis or bronchiolitis, non-emergency health advice telephone service [NHS 111] calls for cough, general practitioner [GP] in-hours consultations for respiratory tract infections, and GP out-of-hours contacts for acute bronchitis or bronchiolitis) were analysed from Dec 29, 2014 to March 13, 2022, for children younger than 5 years. Data were extracted from national laboratory, clinical, and syndromic surveillance systems. Time-series analyses using generalised linear models were used to estimate the effect of non-pharmaceutical interventions targeting SARS-CoV-2 on RSV indicators, with absolute and relative changes calculated by comparing observed and predicted values.Findings RSV-associated activity was reduced for all RSV indicators during winter 2020-21 in England, with 10 280 (relative change -99middot5% [95% prediction interval -100middot0 to -99middot1]) fewer laboratory-confirmed cases, 22middot2 (-99middot6%) percentage points lower test positivity, 92 530 (-80middot8% [-80middot9 to -80middot8]) fewer hospital admissions, 96 672 (-73middot7% [-73middot7 to -73middot7]) fewer NHS 111 calls, 2924 (-88middot8% [-90middot4 to -87middot2]) fewer out-of-hours GP contacts, 91 304 (-89middot9% [-90middot0 to -89middot9]) in-hours GP consultations, and 27 486 (-85middot3% [-85middot4 to -85middot2]) fewer emergency department attendances for children younger than 5 years compared with predicted values based on winter seasons before the COVID-19 pandemic. An unprecedented summer surge of RSV activity occurred in 2021, including 11 255 (1258middot3% [1178middot3 to 1345middot8]) extra laboratory-confirmed cases, 11middot6 percentage points (527middot3%) higher test positivity, 7604 (10middot7% [10middot7 to 10middot8]) additional hospital admissions, 84 425 (124middot8% [124middot7 to 124middot9]) more calls to NHS 111, 409 (39middot0% [36middot6 to 41middot8]) more out-of-hours GP contacts, and 9789 (84middot9% [84middot5 to 85middot4]) more emergency department attendances compared with the predicted values, although there were 21 805 (-34middot1% [-34middot1 to -34middot0]) fewer in-hours GP consultations than expected. Most indicators were also lower than expected in winter 2021-22, although to a lesser extent than in winter 2020-21.Interpretation The extraordinary absence of RSV during winter 2020-21 probably resulted in a cohort of young children without natural immunity to RSV, thereby raising the potential for increased RSV incidence, out-of-season activity, and health-service pressures when measures to restrict SARS-CoV-2 transmission were relaxed.Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available